dockets: FDA-2026-P-10740

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-10740 FDA Requests that the FDA declare that the drug product, Abiraterone Acetate Oral Suspension 500 mg/7.5 mL is suitable for submission in an Abbreviated New Drug Application. Nonrulemaking 2026-09-29T19:06:37Z 0b000064b954fc93                     list_pull

Links from other tables